Market Cap (In INR)
60.52 Billion
Revenue (In INR)
5.7 Billion
Net Income (In INR)
1.19 Billion
Avg. Volume
583.43 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 270.15-835.2
- PE
- -
- EPS
- -
- Beta Value
- 0.304
- ISIN
- INE07RO01027
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Satish Waman Wagh
- Employee Count
- -
- Website
- https://www.supriyalifescience.com
- Ipo Date
- 2021-12-28
- Details
- Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, antihypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.
More Stocks
-
ELECON
-
CSR
-
TKT
-
COGCondor Gold Plc
COG
-
6217
-
AMBO
-
EUX
-
KAMDHENUKamdhenu Limited
KAMDHENU